Analyzing shares of Medical Marijuana Inc (OTCMKTS:MJNA) is always a controversial process. The stock has always been a target for us as a deserving underperformer and something approaching justified approbation. But it is also something that must be filed in the class of “pure-play CBD stories”, which is among the best descriptions right now for a growth theme. So, suffice it to say, there are multiple angles at play.
To add further flesh on the bone, the company just announced that its subsidiary Dixie Botanicals has released new watermelon-flavored cannabidiol (CBD) gummies in response to a growing market demand for edible CBD products. According to the release, “Dixie Botanicals CBD Gummies offer 10 mg of the Company’s hemp-derived CBD isolate in each gummy and are tetrahydrocannabinol (THC)-free. These gummies are minimally processed and have undergone a Triple Lab Tested™ process to verify they are free of contaminants and contain reliable levels of CBD.”
Medical Marijuana Inc (OTCMKTS:MJNA) casts itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.
MJNA’s subsidiary, Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products
MJNA licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products.
In addition, MJNA provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products, sportswear and more.”
According to company materials, “Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.”
Find out when $MJNA reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, MJNA just announced that its subsidiary Dixie Botanicals has released new watermelon-flavored cannabidiol (CBD) gummies in response to a growing market demand for edible CBD products.
Recent action has seen more of the same from MJNA – bad and bearish price action. That’s the stock’s standard modus operandi. But we did some pop on Monday, so we thought we’d give it a closer look. Frankly, this still looks like slow death on a hamburger warmer. But it must be officially recognized that the stock is up about 25% off its recent lows on a jump in volume. So, there’s that.
“According to a recent report by the Brightfield Group, the U.S. market for foods and beverages containing hemp-derived CBD could be worth up to $2.5 billion by 2023 – that’s 10.5% of the $23.7 billion estimated for the market for all CBD products,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “As we continue to innovate, we will also continue to stay abreast of these types of market trends and shifting consumer demands. These new gummies allow us to do just that.”
Now commanding a market cap of $188.3M, MJNA has a significant war chest ($4.7M) of cash on the books, which is balanced by about $8.4M in total current liabilities. Note that its financials are entirely unaudited so who knows where the facts actually are, and one should also note that debt has been growing over recent quarters. MJNA claims to be pulling in trailing 12-month revenues of $69.5M, which would, if true, represent major top-line growth, with y/y quarterly revenues growing at 92%. We will update the story again soon as further details emerge. Sign-up for continuing coverage on shares of $MJNA stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $MJNA, either long or short, and we have not been compensated for this article.